Scaling from Lab to Commercial Production

Overview

Scaling from Lab to Commercial Production is a critical topic for procurement and R&D leaders managing specialty chemical supply chains.

Key Insights

• Dual-source strategies reduce single-point-of-failure risk
• Phase-appropriate quality systems accelerate timelines
• India-based manufacturing offers cost and resilience advantages

Conclusion

Partnering with an R&D-led CDMO can compress development cycles while maintaining regulatory readiness.